Lab Directors Should Follow cfDNA Testing Progress in Ongoing Study
AMP Annual Meeting attendees showed strong interest in the blood test
Emerging Tests-dtet
Diagnostics Pipeline: SimplyTest, Becton Dickinson Expand HPV Testing Capabilities
SimplyTest’s saliva-based HPV tests will be marketed to dentists and functional medicine practices
Quest Says It Will Release a More Powerful Alzheimer’s Test in 2026
The assay detects the presence of three different proteins and is slightly more accurate than a test Quest released earlier this year
Evidence for Liquid Biopsy Lacking, Expert Panel Finds
From - Diagnostic Testing & Emerging Technologies
There is not enough evidence, currently, to support the routine adoption of liquid biopsy tests for any of its promising clinical uses, according to a joint review published…
Dermatology Conference Highlights Gene Expression Tests for Skin Cancer
From - Diagnostic Testing & Emerging Technologies
Several companies presented findings at the American Academy of Dermatology's annual meeting (Feb. 16-18, San Diego) indicating that…
Genotype-Matched Diets Don’t Aid Weight Loss
...
Already a member? Log in here
FDA Set Record in 2017 for Targeted Therapy Approvals
...
Already a member? Log in here
Molecular Testing Increasingly Adopted for Skin Cancer Diagnosis
From - Diagnostic Testing & Emerging Technologies
Dermatopathologists are increasingly using molecular testing for diagnosis of skin cancer samples. Yet, this adoption remains more concentrated in…
FDA Approves First Objective Blood Test for Concussion Evaluation
From - Diagnostic Testing & Emerging Technologies
The U.S. Food and Drug Administration (FDA) recently approved the first blood test to evaluate concussions in adults…
Study Shows Progress Towards a Blood-Based, Multi-Cancer Screen
From - Diagnostic Testing & Emerging Technologies
A blood-based screening test capable of detecting multiple forms of early cancer just took one step closer to becoming a reality. A study published…
Penicillin Skin Testing Can Delabel Misidentified Allergic Patients
From - Diagnostic Testing & Emerging Technologies
In an era of growing concerns over antibiotic stewardship, there is renewed interest in delabeling misidentified penicillin allergies as part of quality improvement efforts…
Basket Study Shows Early Efficacy Targeting Cancer Only On Alterations
From - Diagnostic Testing & Emerging Technologies
Early results from an ongoing "basket study" show that targeted therapies may be effective strictly based on the tumor's molecular profile, and not primary tumor type…
Gene Expression Panels Less Cost-Effective in Real-World Settings
...
Already a member? Log in here